Drug class

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

15 drugs the FDA files under Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.